Accessible at https://doi.org/10.1177/26330040231188979, the Chrysalis Task Force identified key financial and non-financial factors that make rare disease research and development […]
Read More
Under the Horizon Europe Framework Programme, a new two-stage call for proposals for “Establishing novel approaches to improve clinical trials […]
Read More
Coordinated by Dr Guillaume BASSEZ, Dr Gisèle BONNE and Pr Shahram ATTARIAN, the DIU aims to provide theoretical and practical […]
Read More
IRDiRC, a global collaborative initiative with the vision to enable all people living with a rare disease to receive an […]
Read More
In the months of May and June 2022, the European Medicines Agency (EMA) recommended granting various forms of marketing authorisation […]
Read More
A recent report of the joint action Towards the European Health Data Space (TEHDAS) examines EU-level and national funding for health […]
Read More
The European Commission (EC) is inviting interested stakeholders to participate in the open consultation of the Strategic Research and Innovation […]
Read More
EuropaBio continues its Advanced Therapies webinar series of events, interviews, and publications with a virtual discussion on avenues for enhancing the access of […]
Read More